The effect of omeprazole on pediatric chest pain

Evaluation of responses to Omeprazole treatment in children with non-cardiac chest pain

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191208045655N1

Enrollment

144

Registered

2019-12-25

Start date

2018-12-06

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-cardiac Chest Pain. Chest pain, unspecified

Interventions

Intervention 1: Intervention group: A course of treatment with omeprazole at a dose of 1mg / kg daily is prescribed for one week before breakfast for two weeks. Intervention 2: Control group: A placeb

Eligibility

Sex/Gender

All

Age

5 Years to 18 Years

Inclusion criteria

Inclusion criteria: Kids 5-18 years old Complain chest pain that lasts for at least 2 weeks

Exclusion criteria

Exclusion criteria: cardiac chest pain Patient unwillingness to continue collaborating in the study Duration of pain more than 8 weeks History of trauma to the chest point tenderness

Design outcomes

Primary

Measure	Time frame
Chest pain. Timepoint: First, seventh and fourteenth days. Method of measurement: Visual Analogue Scale of pain.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVahid Heydari

Arak University of Medical Sciences

vahid.heidari8818@gmail.com+98 86 3367 5904

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026